SEC Form 4 · accession 0001651844-17-000007
NYMOX PHARMACEUTICAL CORP · NYMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James George Robinson
Director
Period of report
Jul 5, 2017
Accepted (ET)
Jul 7, 2017 · 4:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001018735
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 5, 2017 | P | 500 | $3.94 | A | 3,046,550 | D | |
| Common Stock | Jul 5, 2017 | P | 1,000 | $3.95 | A | 3,047,550 | D | |
| Common Stock | Jul 5, 2017 | P | 2,000 | $3.97 | A | 3,049,550 | D | |
| Common Stock | Jul 5, 2017 | P | 1,500 | $3.99 | A | 3,051,050 | D | |
| Common Stock | Jul 6, 2017 | P | 500 | $3.91 | A | 3,051,550 | D | |
| Common Stock | Jul 6, 2017 | P | 1,000 | $3.92 | A | 3,052,550 | D | |
| Common Stock | Jul 6, 2017 | P | 1,500 | $3.93 | A | 3,054,050 | D | |
| Common Stock | Jul 7, 2017 | P | 1,000 | $4.09 | A | 3,055,050 | D | |
| Common Stock | Jul 7, 2017 | P | 2,500 | $4.13 | A | 3,057,550 | D | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust |
Table II — derivative securities
No Table II lines on this filing.